| MAP2K1 | STE7 | STE | 5hze | A | A | (3s,4r,8s,9s,11e)-8,9,16-trihydroxy-3,4-dimethyl-14-(methylamino)-3,4,5,6,9,10-hexahydro-1h-2-benzoxacyclotetradecine-1,7(8h)-dione | Human | 7569 | 0.59 | |
| MAP2K7 | STE7 | STE | 3wzu | A | | (3s,5z,8s,9s,11e)-8,9,16-trihydroxy-14-methoxy-3-methyl-3,4,9,10-tetrahydro-1h-2-benzoxacyclotetradecine-1,7(8h)-dione | Human | 1239 | 0.52 | |
| MAP3K7 (TAK1) | MLK | TKL | 4gs6 | A | B | (3s,5z,8s,9s,11e)-8,9,16-trihydroxy-14-methoxy-3-methyl-3,4,9,10-tetrahydro-1h-2-benzoxacyclotetradecine-1,7(8h)-dione | Human | 1886 | 0.52 | |
| MAP3K7 (TAK1) | MLK | TKL | 4gs6 | A | A | (3s,5z,8s,9s,11e)-8,9,16-trihydroxy-14-methoxy-3-methyl-3,4,9,10-tetrahydro-1h-2-benzoxacyclotetradecine-1,7(8h)-dione | Human | 1885 | 0.52 | |
| MAPK1 (Erk2) | MAPK | CMGC | 3w55 | A | | (3s,5z,8s,9s,11e)-8,9,16-trihydroxy-14-methoxy-3-methyl-3,4,9,10-tetrahydro-1h-2-benzoxacyclotetradecine-1,7(8h)-dione | Human | 2573 | 0.52 | |
| ACVR1 (ALK2) | STKR | TKL | 6i1s | A | B | (4~{s},5~{r},6~{z},9~{s},10~{s},12~{e})-16-(ethylamino)-4,5-dimethyl-9,10,18-tris(oxidanyl)-3-oxabicyclo[12.4.0]octadeca-1(14),6,12,15,17-pentaene-2,8-dione | Human | 11604 | 1.00 | |
| ACVR1 (ALK2) | STKR | TKL | 6i1s | A | A | (4~{s},5~{r},6~{z},9~{s},10~{s},12~{e})-16-(ethylamino)-4,5-dimethyl-9,10,18-tris(oxidanyl)-3-oxabicyclo[12.4.0]octadeca-1(14),6,12,15,17-pentaene-2,8-dione | Human | 11603 | 1.00 | |
| MAP2K1 | STE7 | STE | 5hze | A | B | (3s,4r,8s,9s,11e)-8,9,16-trihydroxy-3,4-dimethyl-14-(methylamino)-3,4,5,6,9,10-hexahydro-1h-2-benzoxacyclotetradecine-1,7(8h)-dione | Human | 7570 | 0.59 | |